Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

AdoRx Therapeutics Ltd.

AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on modulation of the adenosine pathway. High levels of adenosine in the tumour microenvironment enable cancer to evade the immune system. AdoRx’s lead programs are focused on the design of “fit for purpose” adenosine receptor antagonists that will overcome the effects of high adenosine levels. AdoRx have assembled a team with extensive drug discovery experience. Dr Pete Finan (Novartis, Karus Therapeutics, Yamanouchi), Dr Clive McCarthy (Enterprise Therapeutics, Evotec, Novartis and Rhone Poulenc Rorer) and Dr Roy Pettipher (Orca, Atopix, Wellcome) have discovered and transitioned in excess of twenty-five investigational drugs into clinical development. *

 

Period Start 2017-02-24 established
Products Industry cancer drug
  Industry 2 BIOTECH
Persons Person Finan, Peter (Epidarex Capital 2014– Venture Partner + Karus Therapeutics 201410– Head of Biology before Novartis)
  Person 2 Roper, Elizabeth (Liz) (Epidarex Capital 2013– Partner before Chroma Therapeutics + Wellcome Trust VC team)
     
Region Region Edinburgh
  Country United Kingdom (GB)
  Street 137a George Street
  City EH2 4jY Edinburgh, Scotland
  Tel +44-131-243-3704
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: AdoRx Therapeutics Ltd.. (6/21/18). "Press Release: AdoRx Therapeutics Announces Initial funding of $10 Million for the Discovery of New Cancer Therapeutics". Edinburgh.
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for AdoRx Therapeutics Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top